Development of <sup>64</sup>Cu-NOTA-Trastuzumab for HER2 Targeting: A Radiopharmaceutical with Improved Pharmacokinetics for Human StudiesSang‐Keun Woo, Joo Hyun Kang|Journal of Nuclear Medicine|2018Cited by 66